Codex DNA Inc (DNAY) Down 2.13% in Premarket Trading

Tuesday, July 26, 2022 07:57 AM | InvestorsObserver Analysts

Mentioned in this article

Codex DNA Inc (DNAY) Down 2.13% in Premarket Trading

Codex DNA Inc (DNAY) has fallen Tuesday morning, with the stock decreasing -2.13% in pre-market trading to 1.84. DNAY's short-term technical score of 14 indicates that the stock has traded less bullishly over the last month than 86% of stocks on the market. In the Medical Devices industry, which ranks 119 out of 146 industries, Codex DNA Inc ranks higher than 19% of stocks. Codex DNA Inc has fallen 11.74% over the past month, closing at $2.29 on June 28. During this period of time, the stock fell as low as $1.70 and as high as $2.41. DNAY has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.

DNAY has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on DNAY!

See Full DNAY Report

Codex DNA Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Medical Devices industry which is number 112 by this metric, DNAY ranks better than 112% of stocks.

Important Dates for Investors in DNAY:

-Codex DNA Inc is set to release earnings on 8/9/2022. Over the last 12 months, the company has reported EPS of $-2.16. -We do not have a set dividend date for Codex DNA Inc at this time. Click Here To Get The Full Report on Codex DNA Inc (DNAY)